This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Deidentified data will be shared on request to the corresponding author.
de Winter DP, Kaminski A, Tjoa ML, Oepkes D. Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape. BMC Pregnancy Childbirth. 2023;23:12.
Lyu CJ, Xu C, Yu J, Xia LP. Diagnostic performance of doppler ultrasonography for the detection of fetal anemia: a meta-analysis. Ultrasound Q. 2019;35:339–45.
Christensen RD, Lambert DK, Henry E, Yaish HM, Prchal JT. End-tidal carbon monoxide as an indicator of the hemolytic rate. Blood Cells Mol Dis. 2015;54:292–6.
Christensen RD, Malleske DT, Lambert DK, Baer VL, Prchal JT, Denson LE, et al. Measuring end-tidal carbon monoxide of jaundiced neonates in the birth hospital to identify those with hemolysis. Neonatology. 2016;109:1–5.
Pakdeeto S, Christensen TR, Bahr TM, Gerday E, Sheffield MJ, Christensen KS, et al. Reference intervals for end tidal carbon monoxide of preterm neonates. J Perinatol. 2022;96:448–50.
Friedman P, Guo XM, Stiller RJ, Laifer SA. Carbon monoxide exposure during pregnancy. Obstet Gynecol Surv. 2015;70:705–12.
Baum M, Schiff E, Kreiser D, Dennery PA, Stevenson DK, Rosenthal T, et al. End-tidal carbon monoxide measurements in women with pregnancy-induced hypertension and preeclampsia. Am J Obstet Gynecol. 2000;183:900–3.
Kreiser D, Baum M, Seidman DS, Fanaroff A, Shah D, Hendler I, et al. End tidal carbon monoxide levels are lower in women with gestational hypertension and pre-eclampsia. J Perinatol. 2004;24:213–7.
We thank Sasikarn Pakdeeto MD, Neonatology, Mahidol University, Bangkok, Thailand for the original illustration and for reviewing the manuscript. We also thank Molly Adams, Intermountain Health Research, for assistance with the IRB review. We also thank Paul Vanasco MT(ASCP) and Terry Rees MT(ASCP)(SBB) of the Intermountain Health Transfusion Service for expert technical assistance. We also thank Robert L. Andres MD, Paul W. Whitecar MD, Douglas S. Richards MD, and Ibrahim A. Hammad, MD for referring patients for study.
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Bahr, T.M., Christensen, T.R., Cheatham, L.S. et al. Feasibility of a non-invasive method to assess fetal hemolysis in utero during the third trimester. J Perinatol 43, 1437–1439 (2023). https://doi.org/10.1038/s41372-023-01764-8